ArticleMolecular therapy : the journal of the American Society of Gene Therapy2013

Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

Xuanming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.